Finance

Lists
Why is 4TZ up 2.94%?
Dive Deeper
4TZ:FRA
ORIC Pharmaceuticals Inc
€10.50
+2.94%
(+0.30) 1D
Oct 9, 3:47:18 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 4TZ...
Open
€10.54
High
€10.54
Low
€10.50
Mkt. cap
1.25B
Avg. vol.
0.00
Volume
0.00
52-wk high
€12.32
52-wk low
€6.10
No. of employees
111
Open
€10.54
High
€10.54
Low
€10.50
Mkt. cap
1.25B
Avg. vol.
0.00
Volume
0.00
52-wk high
€12.32
52-wk low
€6.10
No. of employees
111
News stories
From web sources and news partners
About ORIC Pharmaceuticals Inc
CEO-
Employees111
Founded2014
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websiteoricpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
28.77M
25.86M
31.44M
36.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.90M
8.70M
8.18M
9.00M
Operating expense
36.67M
34.55M
39.62M
45.30M
Total operating expenses
36.67M
34.55M
39.62M
45.30M
Operating income
-36.67M
-34.55M
-39.62M
-45.30M
Other non operating income
-
-
-
-
EBT including unusual items
-32.59M
-30.50M
-35.77M
-41.49M
EBT excluding unusual items
-32.59M
-30.50M
-35.77M
-41.49M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-32.59M
-30.50M
-35.77M
-41.49M
Net profit margin
-
-
-
-
Earnings per share
-0.33
-0.30
-0.34
-0.38
Interest and investment income
4.08M
4.05M
3.85M
3.80M
Interest expense
-
-
-
-
Net interest expenses
4.08M
4.05M
3.85M
3.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
-36.38M
-34.23M
-39.35M
-45.03M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps